BRENTUXIMAB VEDOTIN CONSOLIDATION TO REDUCE RADIATION USE IN PATIENTS WITH LIMITED STAGE NONâBULKY HODGKIN LYMPHOMA: AN UPDATE FROM a PHASE 2 CLINICAL TRIAL
Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 81-82
10.1002/hon.2437_69